Email Updates
Go to Basic Search
Results
Total Results: 60 records
Showing results for "adverse".
-
June 2021 CDS Connect Work Group Slides (pdf file)
cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdfJanuary 01, 2021 - 14.3% of inpatients ► 231,000 US emergency department visits • Hospital admissions associated with an adverse … Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. … newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse -
Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An eCQM-derived CDS (pdf file)
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM_0.pdfSeptember 01, 2022 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … The CQL logic is unchanged from v4 and still contains adverse effects, allergies, and intolerances. … A value set for muscle symptoms was added and the adverse effects, allergies, and intolerances value -
Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An eCQM-derived CDS (pdf file)
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM.pdfSeptember 01, 2022 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … The CQL logic is unchanged from v4 and still contains adverse effects, allergies, and intolerances. … A value set for muscle symptoms was added and the adverse effects, allergies, and intolerances value -
cds.ahrq.gov/sites/default/files/cds/artifact/21/2023_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdfJanuary 01, 2023 - Patient has known adverse reactions to statins. ii. … Patient is likely to have adverse reactions to statins. iii. … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … The CQL logic is unchanged from v5; it still contains adverse effects, allergies, and intolerances. … A value set for muscle symptoms was added; the adverse effects, allergies, and intolerances value set
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdfJanuary 01, 2024 - Patient has known adverse reactions to statins. ii. … Patient is likely to have adverse reactions to statins. iii. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … The CQL value set and logic differ in that they contain adverse effects, allergies, and intolerances
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdfApril 01, 2021 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … Denominator Exceptions: Patients with adverse effect, allergy, or intolerance to statin medication. … OR breastfeeding OR breastfeeding observation within the past year 21 OR rhabdomyolysis OR adverse
-
CDS Connect Implementation Guide Draft (doc file)
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docxOctober 01, 2017 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … DENOMINATOR EXCEPTIONS: Patients with adverse effect, allergy, or intolerance to statin medication. -
Warfarin-Nsaids Mdia Implementation Guide (doc file)
cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docxNovember 11, 2019 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse -
CDS Connect Implementation Guide Draft (doc file)
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docxOctober 01, 2017 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse -
CDS Connect Work Group June 2021 Summary (pdf file)
cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdfJanuary 01, 2021 - weighs the risk factors to produce a risk array that visually represents the estimated risk of an adverse -
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docxAugust 29, 2020 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse
-
cds.ahrq.gov/taxonomy/term/4491July 05, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
-
cds.ahrq.gov/taxonomy/term/2136May 31, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
-
Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdfJanuary 01, 2020 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse -
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdfJanuary 01, 2024 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … implement CQL code, along https://github.com/AHRQ-CDS/CQL-Testing-Framework 15 with any potential adverse … Testing should also ensure that implementation of the artifact has no adverse effect on the processing
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact_Updated%20Nov%202019.pdfNovember 01, 2019 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdfApril 01, 2021 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … 21 IT products to understand their capacity to implement CQL code, along with any potential adverse … Testing should also ensure that implementation of the artifact has no adverse effect on the processing
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdfSeptember 01, 2022 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their capacity to implement CQL code, along with any potential adverse … Testing should also ensure that implementation of the artifact has no adverse effect on the processing
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdfJanuary 01, 2023 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their capacity to implement CQL code, along with any potential adverse … Testing should also ensure that implementation of the artifact has no adverse effect on the processing
-
CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdfSeptember 01, 2021 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse
SHARE:
Search the AHRQ Archive
Information and reports more than 5 years old may be found in the AHRQ Archive site.
Search Within A Specific AHRQ Site
You selected to view results for the following site:
